289 related articles for article (PubMed ID: 12605722)
21. Programmatic goals and approaches to onchocerciasis.
Richards F; Hopkins D; Cupp E
Lancet; 2000 May; 355(9216):1663-4. PubMed ID: 10905239
[TBL] [Abstract][Full Text] [Related]
22. Ocular onchocerciasis: current management and future prospects.
Babalola OE
Clin Ophthalmol; 2011; 5():1479-91. PubMed ID: 22069350
[TBL] [Abstract][Full Text] [Related]
23. [Control of onchocerciasis vectors in West Africa: description of the logistics adapted for a large-scale public health program].
Hougard JM; Poudiougo P; Zerbo G; Meyer R; Guillet P; Agoua H; Seketeli A; Akpoboua A; Sowah S; Samba EM
Sante; 1994; 4(6):389-98. PubMed ID: 7850190
[TBL] [Abstract][Full Text] [Related]
24. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
[TBL] [Abstract][Full Text] [Related]
25. Progress toward elimination of onchocerciasis in the Americas - 1993-2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 May; 62(20):405-8. PubMed ID: 23698606
[TBL] [Abstract][Full Text] [Related]
26. [The campaign against onchocerciasis in Africa: update].
Boussinesq M; Hougard JM
Med Trop (Mars); 1998; 58(3):285-96. PubMed ID: 10088109
[TBL] [Abstract][Full Text] [Related]
27. Onchocerciasis control: the APOC strategy.
Dadzie KY
Afr Health; 1997 Mar; 19(3):13-5. PubMed ID: 12292398
[TBL] [Abstract][Full Text] [Related]
28. Importance of ivermectin to human onchocerciasis: past, present, and the future.
Cupp EW; Mackenzie CD; Unnasch TR
Res Rep Trop Med; 2011; 2():81-92. PubMed ID: 30881181
[TBL] [Abstract][Full Text] [Related]
29. Genome-based tools for onchocerciasis elimination: utility of the mitochondrial genome for delineating Onchocerca volvulus transmission zones.
Crawford KE; Hedtke SM; Doyle SR; Kuesel AC; Armoo S; Osei-Atweneboana MY; Grant WN
Int J Parasitol; 2024 Mar; 54(3-4):171-183. PubMed ID: 37993016
[TBL] [Abstract][Full Text] [Related]
30. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
Ndyomugyenyi R; Lakwo T; Habomugisha P; Male B
Ann Trop Med Parasitol; 2007 Jun; 101(4):323-33. PubMed ID: 17524247
[TBL] [Abstract][Full Text] [Related]
31. Onchocerciasis in West Africa after 2002: a challenge to take up.
Hougard JM; Yameogo L; Philippon B
Parasite; 2002 Jun; 9(2):105-11. PubMed ID: 12116855
[TBL] [Abstract][Full Text] [Related]
32. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
33. Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
Koala L; Nikiema A; Post RJ; Paré AB; Kafando CM; Drabo F; Traoré S
Acta Trop; 2017 Feb; 166():96-105. PubMed ID: 27845063
[TBL] [Abstract][Full Text] [Related]
34. Optimization and evaluation of the Esperanza Window Trap to reduce biting rates of Simulium damnosum sensu lato in Northern Uganda.
Loum D; Cozart D; Lakwo T; Habomugisha P; Jacob B; Cupp EW; Unnasch TR
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007558. PubMed ID: 31310607
[TBL] [Abstract][Full Text] [Related]
35. Four TDR diseases can be "eliminated". 4. African onchocerciasis control: patients to take over by 2008.
TDR News; 1996 Mar; (49):4-5. PubMed ID: 12294420
[TBL] [Abstract][Full Text] [Related]
36. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.
Zouré HG; Noma M; Tekle AH; Amazigo UV; Diggle PJ; Giorgi E; Remme JH
Parasit Vectors; 2014 Jul; 7():326. PubMed ID: 25053392
[TBL] [Abstract][Full Text] [Related]
37. The Mectizan Donation Program - highlights from 2005.
Alleman MM; Twum-Danso NA; Thylefors BI
Filaria J; 2006 Sep; 5():11. PubMed ID: 17005039
[TBL] [Abstract][Full Text] [Related]
38. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).
Noma M; Nwoke BE; Nutall I; Tambala PA; Enyong P; Namsenmo A; Remme J; Amazigo UV; Kale OO; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S29-39. PubMed ID: 12081248
[TBL] [Abstract][Full Text] [Related]
39. Operational Performance of the
Richards FO; Katabarwa M; Bekele F; Tadesse Z; Mohammed A; Sauerbrey M; Dominguez-Vazquez A; Rodriguez-Perez MA; Fernández-Santos NA; Rizzo N; Schuler Martínez HR; Lovato Silva R; Morales Monroy Z; Habomugisha P; Oguttu DW; Zarroug IMA; Aziz NA; Unnasch TR
Am J Trop Med Hyg; 2018 Sep; 99(3):749-752. PubMed ID: 30014821
[TBL] [Abstract][Full Text] [Related]
40. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
Kim YE; Sicuri E; Tediosi F
PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
